TRANSPHARMAC LIMITEDActive

Company number SC729695Private limited companyIncorporated 2022

Key figures

−£7,070-1,132.1%
Net assets 2025/26
-10 k010 k20 k30 k2022/232023/242024/252025/26

Like most small UK companies, TRANSPHARMAC LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
025 k50 k75 k2022/232023/242024/252025/26
Filed accounts2022/23–2025/26
2022/232023/242024/252025/26
Total assets36,58472,23918,50911,316
Total liabilities———18,386
Net assets / total equity1,42625,809685-7,070
Average number of employees0000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: TRANSPHARMAC LIMITED

Company

TRANSPHARMAC LIMITED is a private limited company registered with Companies House under company number SC729695. It was incorporated on 14 Apr 2022. Its status is active. The registered office is in Edinburgh (EH13). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2025/26 (period ending 30 Apr 2026); the company files micro-entity accounts. Net assets were −£7,070, down 1,132.1% on the previous year. Total assets were £11,316 and total liabilities £18,386. The company had an average of 0 employees. Figures are available for 4 financial years (2022/23–2025/26).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jan 2028. The next confirmation statement is due by 27 Apr 2027.